TH and benign prostatic hyperplasia: We first demonstrated that the systemic administration of the SNS denervation agent, 6-OHDA, to BPH/2J mice significantly reduces the heightened SNS innervation in WAT, as evidenced by the reduction of tyrosine hydroxylase expression.